Connect Biopharma Holdings Ltd reports results for the quarter ended December 31 - Earnings Summary

• Connect Biopharma Holdings Ltd CNTB.OQ reported a quarterly adjusted loss of 27 fen​​ per share for the quarter ended December 31. The mean expectation of five analysts for the quarter was for a loss of 99 fen per share. Wall Street expected results to range from CNY-2.28 to -28 fen per share.

• Reported revenue was zero​; analysts expected CNY3.75 thousand.

• Connect Biopharma Holdings Ltd's reported EPS for the quarter was a loss of 27 fen​.

• The company reported a quarterly loss of CNY15.11 million.

• Connect Biopharma Holdings Ltd shares had risen by 2.8% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 1.7% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Connect Biopharma Holdings Ltd is $7.50, about 65.1% above its last closing price of $2.62

This summary was machine generated from LSEG data March 31 at 10:58 p.m. UTC. ​All figures in Chinese yuan renminbi unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)